Contrary to our findings, a recent study proposed that PD-1 contributes not only to immune suppression of effector T cells but also to PD-1 expressing regulatory T cells in the tumor of non-small cell lung cancer patients. The gene discussed is PDCD1; the disease is neoplasm.